Cargando…
Mitochondrial derived peptide MOTS‐c prevents the development of heart failure under pressure overload conditions in mice
MOTS‐c, a mitochondrial‐derived peptide (MDP), has been shown to have multiple biological activities such as antioxidation, anti‐inflammation, and anti‐apoptosis properties. In the present study, we aimed at evaluating the therapeutic effect of MOTS‐c peptide in an animal model of heart failure. The...
Autores principales: | Zhong, Peng, Peng, Jianye, Hu, Yewen, Zhang, Jun, Shen, Caijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639045/ https://www.ncbi.nlm.nih.gov/pubmed/36156853 http://dx.doi.org/10.1111/jcmm.17551 |
Ejemplares similares
-
MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload
por: Ribeiro Junior, Rogério Faustino, et al.
Publicado: (2018) -
The protective effect of the mitochondrial-derived peptide MOTS-c on LPS-induced septic cardiomyopathy: Effect of MOTS-c on septic cardiomyopathy
por: Wu, Jiaqi, et al.
Publicado: (2023) -
The mitochondrial‐derived peptide MOTS‐c: a player in exceptional longevity?
por: Fuku, Noriyuki, et al.
Publicado: (2015) -
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation
por: Zheng, Yuejun, et al.
Publicado: (2023) -
Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
por: Kong, Byung Soo, et al.
Publicado: (2023)